After recent FDA approval of the use of the Philips MR-only radiotherapy simulator, or MRCAT, for treatment planning related to primary and metastatic tumors in the brain, the University of Florida Department of Radiation Oncology will be the first to offer its technology in the United States.
The MRCAT Brain clinical application allows for consistent management from diagnosis to treatment planning, employing the highest of definition and precision MR Imaging without the need for computed tomography (CT) scans.
With the MRCAT Brain, the entire process can be completed within the UF Radiation Oncology Department, eliminating the need for arduous CT-MRI registration and thus reducing uncertainties, complexity, and risks related to missed treatment targets or unintended exposure.
Further, the MRCAT Brain uses Artificial Intelligence (AI) for fast computation of treatment data, aiding treating physicians and medical physicists in the construction of more accurate, precise, safe and effective treatment planning.
